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Abstract. Two l-methyl-3-arylpropane-1,3-diones viz., 1-methyl-3-(2',4'-dimethoxy- 
pheny1)- and 1-methyl-3-(3',4'-dimethoxyphenyl) propane-1,3-diones have been synthe- 
sised and coupled with diazotised simple and sulphonamide bases in presence of 
sodium acetate to furnish the corresponding 1-methyl-3-(2',4'-/3',4'-dimethoxypheny1)- 
2-(arylazolN-substituted p-sulphamylbenzeneazo) propane-1,3-diones. All these com- 
pounds were later subjected to in vitro screening against S. aureus, E. coli and 
P. pyocyanea when these showed considerable activity. 
1. Introduction 
Encouraged by the findings of our earlier work on the structure activity relationship of 
1-methyl-3-aryl- and 1,3-diaryl-2-(N-substituted p-sulphamylbenzeneazo) propane-1,3- 
d i~nesl -~  we have now extended this work by synthesising 1-methyl-3-aryl propane-1,3- 
diones having two methoxyl groups in different positions of the phenyl ring and their 
coupling with 'different diazotised simple and sulphonamide bases. This work is 
expected to provide an opportunity to evaluate the effect of introducing and additional 
methoxyl group on the rate of coupling reaction and antibacterial properties of the 
slnthesised compounds. 
The present paper describes the synthesis of 1-methyl-3-(2',4'-dimethoxypheny1)- 
and 1-methyl-3-(3',4'-dimethoryphenyl) propane- 1,3-diones and their coupling with 
simple and sulphonamide bases to furnish the corresponding 1-methyl-3-(2',4'-/3',4'- 
dimethoxypheny1)-2-(arylazo/N-substituted p-sulphamylbenzeneazo) propane-1,3-diones 
of the type as shown in Fig. l(a, b). The homogeneity and purity of all the 
compounds were checked by TLC and elemental analysis and structure assigned on the 
(basis of IR and NMR spectral studies. All the synthesised products were later 
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subjected to in vitro screening against S. aureus, E. coli and P. pyocyanea at two 
different concentrations of 50 t~glml and 100 pg/ml. 
(a) Ar - 2,4- and 3,4-dimethoxyphenyl; R = C6H4Rt 
Fig' A" - 2,4- 4-dimethoxyphenyl; R = C6H,S02NHR' 
2. Experimental Procedure 
1-Methyl-3-(2',4'-dimethoxyphen1y)- and 1-methyl-3-(3',4'-dimethoxyphenyl) propane- 
1,3-diones required for this work were prepared following the standard method of 
condensing the appropriate ketone with ethyl acetate in presence of sodium in dry 
ether. Both the p-diketones were purified through their cppper complexes. 
Synthesis of I-methyl-3-(2',4'-13' 4'-din?ethoxyphenyl)-2-(arylazo/~-substituted p-sul- 
phamylbenzeneazo) propane-1,3-diones 
To an ice-cold and well stirred solution of 1-methyl-3-(2',4'-/3',4'-dimethoxypheny1)- 
propane-1,3-dione (0.002 mol) in ethanol (50 ml) containing sodium acetate (6 g) was 
slowly added a diazotised solution of sulphonamide or simple base (0.002 mol) with 
continuous stirring and cooling (0-5"). The yellow coloured azo compound was 
precipitated by the addition of water and after further stirring for five minutes, the 
.separated solid was filtered, washed well with water and dried. 
Pure I-nzethyl-3-(2', 4'-3',4'-dimethoxypheltyl) - 2 - (aryla~o/~V-substituted p-sulphamyl- 
benzeneazo)propane-l,3-dione was crystallised from ethanol, acetic acid or DMF or from 
a mixture of any two of the above solvents (Table 1). 
The NMR spectrum (CDCI,) of 1-methyl-3-aryl propane-] ,3-diones indicate 
that 1 -methyl-3-(3',4'-dimethoxyphenyl) propane- 1 ,3-dione is 99 % in the enolic 
(chelated) form, because the signal at 4.15 6, (- CO -CH,- C-) is very week and 
I1 
- 0  
0 
II 
= CH--C gives a signal at 6.3 6, which is not the position in case of I-methyl-3- 
(2',4'-dimethoxyphenjl) propane-1,3-dione (Table 2). Further, a hump in the region 
16.6 6, (OH protons) has moved downfield (18.9 6) in the case of 1-methyl-3-(3',4'- 
dimethoxyphenq1)propane-1,3-dione which can be attributed to its involvent in 
hydrogen bonding. 
In the NMR spectrum of 1-methyl-3-aryl-2-(arylazo/N-substituted p-sulphamyl- 
benzeneazolpropane- l,3-diones, a peak in the region 2.57 rt 0.10 6, characterstic of 
methyl group attached to a keto group is observed (Table 3). There are two peaks 
for two methoxyl groups in the region 3.75-4.1 6; the one due to methoxyl group near 
the electron attrdcting group (> C = 0 )  will be observed little down field as compared 
to that due to methoxyl group attached at the para position with respect to the keto 
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group. Two humps in the region 15.18-15.40 8 and 13.5-14.5 6 in case of 2-arylazo 
derivatives and - 12.8 8 and - 11.3 8 in 2-(N-substituted p-sulphamy1benzeneazo)- 
derivatives can be attributed to OH and h.%I protons respectively which indicates the 
presence of azo and hydrazono form in equilibrium. 
The IR spectral studies of I-methyl-3-aryl-2-(N-arylazo/~-substituted p-sulphamyl- 
benzeneazo)propane- 1,3-diones show a peak in the region - 1650 cm-l and sharp 
peaks in the region 1565- 1595 cm-I and 1 156- 1 170 cm-I, which could be assigned to 
keto, azo and CH,-C-groupings (Table 4). Further a sharp peak in the range 808 
II 
0 
to 844 cm-l and peaks of medium or weak intensity in the region 833-890 cm-1 are 
indicative of the presence of 1,2,4-substituted phenyl ring; in the bands in the region 
685-790 cm-l represent differently substituted phenyl rings. I R  spectra of 
2-(N:substituted p-sulphamylbenzeneazo)propane- 1.3-diones show the symmetrical 
and asymmetrical stretching frequencies due to S= 0 group in the range 1090-1 120 
cm-I and 1260-1 350 cm-l respectively. However, no bands in the region 320G-3400 
cm-I in the IR spectrum (KBr pellets) of different aryl azo derivatives are observed 
thereby supporting the arylazo structure. 
During the coupling reaction, it has been observed that by the introduction of 
another methoxy group in the phenyl ring of the propane-1,3-dione, the rate of 
coupling in general decreases thereby giving lower yields. This is in confirmation 
with our earlier observation4 that introduction of an electron releasing group decreases 
the rate of coupling reaction. However, when compared among themselves it was 
observed that shifting of one of the methoxyl group from ortho to the meta position 
in phenyl ring of the dione, with respect to one already present, the rate of coupling 
increases. 
3. Evaluation of antibacterial activity 
The results of the antibacterial tests at 50 pg/ml indicates that a fairly large number 
of compounds exhibit considerable activity against all the three micro-organism. 
The azo compounds synthesised from sulphonamide bases are far more active than 
their corresponding simple azo analogues with few exceptions. When the results of 
screening of these compounds were compared with those of I-methyl-3-(4'methbxy- 
pheny1)-2-(N-substituted p-sulphamylbenzeneazo)propane- 1 ,3-dione3, it became clear 
that the introduction of an additional methoxyl group at ortho or meta position to the 
one already present caused an overall increase in the activitiy. 
On comparing the results of 2-(arylazolN-substituted p-sulphamylbenzeneazo) deri- 
vatives of the two series among themselves, it is observed that if a methoxyl group is 
changed from ortho to the nieta position, the azo compounds by and large show 
considerable increase in activity against all the three micro-organisms. 
Again, if the results are compared on the basis of changes made in the substitution 
pattern of the phenyl ring attached through an azo linkage, keeping all the other 
substituents unaltered, it is observed that the replacement of methyl group by a 
halogen atom, the activity against all the three increases but relatively more against 
Table 1. I-Methyl-3-(2',4'-dimethoxyphenyl)-2-(arylazo)propane-1,3-diones 
(Fig. la  : Ar = 2,4-Dimethoxyphenyl) 
SI. No. R' M.P. Colour Yield Crystallisation Molecular Percentage . I  I < I  ,I 
("c) (%) solvent formula - A - -  7 -  s 
Found ' Requires J I I' 2 
: H  C H < [  I % 
- - 
1. If 105 Y 70 EtOH CiaH1804Na 66.2 5.3 66.2 5.5 ++ 
2. o-Methyl 131-2 YF 65 AcOH/DMF Cl~HPo04N2 67.0 6.0 67.1 5.9 + ++ 
3. m-Methyl 116 0 63 EtOH cioHaoo4Na 67.3 5.9 67.1 5.9 + 
4. p-Methyl 122 Y 60 EtOH . ~ ~ B ~ s o ~ ~ ~ o  67.0 6.1 67.1 5.9 
5. o-Chloro 160 YN 72 AcOH/DMF C18H1704NaCI 60.1 4.9 60.0 4.7 
6. m-chloro 166 YN 70 EtOH/AcOH C18H1704N2CI 59.8 4.6 60.0 4.7 + 
7. p-Chloro 134 YF 75 EtOH/AcOH ClaH1704N2CI 60.0 4.7 60.0 4.7 + 
8. 0-Bromo 171 Y 82 DMF C18H170aNaBr 53.5 4.2 53.3 4.2 
9. p-Bromo 146 Y 75 EtOHIAcOH Cl8H,,O4Ar2Br 53.2 4.4 53.3 4.2 ++ 
10. o-Nitro 189 YN 74 AcOH!DMF Cl8HI7o6N3 58.0 4.6 58.2 4.5 + ++ 
11. m-Nitro 133 Y 75 EtOHlAcOH C1&706N3 58.1 4.6 58.2 4.5 + 
12. p-Nitro 164 YF 73 AcOHIDMF C18H1706N3 58.4 4.5 58.2 4.5 ++ +++ 
13. 0-Methoxy 135-6 0 68 EtOHIAcOH C19Hao06Ns 63.8 5.3 64.0 5.6 + + + + 
14. m-Methoxy 103 B 65 EtOH/AcOH Cl,H,o06Na 64.1 5.5 64.0 5.6 ++ ++ + 
15. 23-Dichloro 178-9 Y 75 AcOH/DMF Cl8HI6O4N2Cla 55.0 4.1 54.8 4.1 + . - 
Table 2. l-Methyl-3-(3',4'-dimethoxyphcnyI)-2-(arylazo)propane-1,3-diones 
(Fig. l a  : Ar = 3,CDimethoxyphenyl) 
6. 
'+ 
SI. No. R M.P. Colour Yield Crystallisation Molecular Percentage Antibacterial acthity 3' 
("3 (%) solvent formula ,--------- r--- A-, 
Found Requires S E. - P. 3 
c H .  c H oureus COR ~yocyanea 3 
. ~ .<." ," "* *,  %",< * . .  - ' - 3 
a 
1. H 168 Y 70 EtOHIAcOH Cl,H,,04N, 66.2 5.5 66.2 5.5 - + 3 
2. o-Methyl 117 Y F  63 EtOHIAcOH ClpHeo04N, 67.0 6.1 67.1 5.9 - 4- t% cl 
3. nr-Methyl 164 Y F  67 EtOH/AcOH C18H2004Na 67.1 6.0 67.1 5.9 4-+ 
4. p-Methyl 153 YO 67 EtOHIAcOH C,,H,,O4N, 67.3 5.9 67.1 5.9 A + 
5 o-Chloro 118 Y 76 EtOHIAcOH Cl8Hl7O4NZCI 60.0 4.9 60.0 4.7 y -- 6. rn-Chloro 131 YN 73 EtOHIAcOH C,,H,,O,N,CI 59.8 4.8 60.0 4.7 f + - 
7. p-Chloro 160 Y 78 EtOH/AcOH Cl,Hl,O,N,CI 60.1 4.5 60.0 4.7 +; - - 
8. o-Bromo 138 YF 78 EtOHIAcOH Cl,H1704N,Br 53.3 4.2 53.3 4.2 + - 
9. p-Bromo 163 YN 75 EtOHlAcOH C18H1704N2Br 53.5 4.5 53.3 4.2 -b 
10. o-Nitro 171 PY 75 EtOHIAcOH Cl8Hl,OIN, 58.1 4.7 58.2 4.5 - 
11. rn-Nitro 204 LY 75 AcOHIDMF C,,H170,N, 58.0 4.5 58.2 4.5 4- 
12. p-Nitro 210 Y 79 AcOHIDMF C18H,,0,N, 58.3 4.5 58.2 4.5 4- 
13. o-Methoxy 148 RO 72. EtOH/AcOH C,,H,,O,N, 64.2 5.4 64.0 5.6 
14. n1-Methoxy 172 0 63 EtOH/AcOH C,,H,,O,N, 64.1 5.7 64.0 5.6 -l- 4- 
15. 2.5-Dichloro 188 Y 76 AcOH/DMF C18H1604N2CIz 55.0 4.3 54.8 4.1 + 
Table 3. 1-Melh~l-3-(2'.4'-dimethoxyphenyl)-2-(N-substituted p-sulphamylbenzeneazo)propane-1,3-diones 
(Fig. Ib : Ar = 2,4-Dimethoxyphenyl) 
SI. No. R M. P. 
("C) 
1. H 203 
2. Acetyl 205 
3. Phenyl 183 
4. o-Methylphenyl 160 
5. m-Methylphenyl 169 
6. p-Methylphenyl 165 
7. o-Chlorophenyl 168 
8. m-Chlorophenyl 169 
9. p-Chlorophenyl 167 
10. p-Bromophenyl 171 
11. Guanidyl 218 
12. a-Pyridyl 170 
13. Pyrimidyl 206 
14. 2,CDimethyl- 188 
pyrimidyl 
15. 4,6-Dimethyl- 140 
pyrimidyl 
16. 2.6-Dimethyl- 145 
pyrimidyl 
17. 5-Methyl-1,3,4- 122 
thiadiazol-2-yl 
18. m-Nitrophenyl 178 
19. p-Nitmphenyl 186 
20. o-Methoxyphenyl 163 
21. 4-Methylpyrimidyl 196 
22. I-Phenyl- 145 
pyrazol-4-yl 
23. Thaizol-2-yl 192 
Colour Yield Crystallisation Molecular Percentage Antibacterial activity 
(%) solvent formula ----7 
Found Requ~res S. E. P 
C H C H uureus ol i  pyocyuneu 0, n 
YF 73 AcOHIDMP C18H,,0eNsS 5 4.9 53.3 4.7 + ++f+ ++ 
- 
$ 
YP 74 AcOHlDMF C,,H~,O,N,S 53.7 4.7 53.7 4.7 + + 
Y 76 EtOHIAcOH C,H,,O.NsS 60.0 5.0 59.8 4.8 + - + + o, 
-. 
YO 65 EtOHiAcOH C,,H,,O,N,S 60.7 5.3 60.6 '5.5 - ++++ ++f 9 
B 63 EtOHIAcOH C.,Ha,O,N.S 60.6 5.8 60.6 5.5 +++ + + - > 
Y 60 EtOHIAcOH C.,H,,O,N,S 60.8 5.4 60.6 5.5 +++ + + +++ 
Y 75 AcOHIDMF C,H,,O,N8SCI 55.8 4.2 55.7 4.2 ++++ + + + + 
YN 76 AcOHtDMF C,,H,.O,N,SCl 55.9 4.1 55.7 4.2 ++++ t ++ 
LY 74 EtOHIAcOH C,,H,,O.N,SCI 55.7 4.4 55.7 4.2 ++ + f ++ 
B 76 EtOHiAcOH C,,H,,O.N,SBr 51.0 4.1 51.0 3.8 +++ +++ +++ 
LY 75 AcOHIDMF C,,HI,O,NpS 51.3 4.7 51.0 4.7 ++ + + + 
Y 65 EtOHIAcOH Cs3H2?OaNaS 57.5 4.8 57.4 4.6 ++ ++ + 
PY 73 EtOH/AcOH C,,H,,O.N,S 55.0 4.3 54.9 4.3 ++++ + + +++ 
Y 70 EtOHIAcOH C,H,,O.N.S 56.5 5.0 56.3 4.9 +++++ +++ ++ 
YF 74 EtOH C,H,.O,NsS 56.3 5.0 56.3 4.9 +++ + + 
Y 76 EtOHIAcOH C,,H,,O.N,S 53.2 5.1 53.0 4.8 +++++ - + 
PY 63 EtOHiAcOH C,,H,,O.N.S, 50.0 4.2 50.1 4.2 + +++++t 
LY 76 EtOHIAcOH CmHx30aN4S 54.6 4.0 54.5 4.1 - + t f  +f+ 
B 78 EtOHIAcOH CJisH,,08N4S 54.7 4.3 54.5 4.1 - - +++ 
RB 74 EtOHIAcOH C2Jfs607NJ 58.9 5.0 58.7 4.5 - - +++++ 
B ' 7 5  EtOHlAcOH C,,H,,O.N.S 55.3 4.6 55.5 4.6 + - + 
B 65 EtOHjAcOH C*,H,,O,N,S 59.1 4.3 59.2 4.5 - + + + 
Y 68 EtOHIAcOH C,,H,,O,N,S, 51.4 4.0 51.6 4.1 - - i 
SI. 
Table 4. 1-Methyl-3-(3',4'-dimethoxyphenyl)-2-(N-substituted p-sulphamylbenzeneazo)propane-1,3-diones 
(Fig. I b: A r  = 3,4-Dimethoxyphenyl) 
No. R M. P. Colour Yield Crystallisation Molecular Percentage Antibacterial activity 
CC) (%I solvent formula h ----- 7 
Found Requires S.  E. P. 
C H C H aureus coli phyocyanea 
H 202 Y 65 AcOH/DMF C18Hl,06N3S 53.3 4.5 53.3 4.7 
Acetyl 204 Y 56 AcOH/DMF C2,H210,N3S 53.9 41.7 53.7 4.7 + - 
Phenyl 156 YF 62 EtOH/AcOH CZ4Hz3O,N3S 60.0 41.7 59.8 4.8 - f;: 
s 
o-Methylphenyl 191 LY 60 EtOH/AcOH C2,H2,0,N3S 60.6 5.5 60.6 5.5 + 8 
m-Methylphenyl 186 LY 62 EtOHIAcOH CZ6H2,O,N3S 60.8 5.5 60.6 5.5 f + 3 ' 
p-Methylphenyl 189 FY 64 EtOHlAcOH C2,H2,0,N,S 60.4 58.4 60.6 5.5 h 
' B 
o-Chlorophenyl 172 YF 68 EtOH/AcOH CZ,H2,O6N3SCI 55.9 4.3 55.7 4.2 ++ + 
m-Chloroph~nyl 175 Y 65 EtOHIAcOH Cz4H2,06N3SCI - 
% 
55.7 41.5 55.7 4.2 ++ 
- 
s 
p-Chlorophenyl 222 Y 66 DMFIEtOH Cz4Hz206N3SCl 55.6 4C1 55.7 4.2 ++ f 
p-Bromophenyl 225 YN 70 DMFIEtOH Cz4HZ2O6N3SBr 58.8 41.0 58.9 3.9 - !I 
Guanidyl 193 B 72 AcOH/DMF ClgHz106N6S 51.2 41.6 51.0 4.7 + 8 s 
a-Pyridyl 213 Y 63 AcOHIDMF Cz3HZ2O,N4S 57.4 41.8 57.4 4.6 - 
Pyrimidyl 247 YN 70 AcOHIDMF C12H2106N6S 55.0 4.2 54.9 4.3 4- 
2,6-Dimethyl- 165 LY 66 DMF/EtOH C24H2s06N$ 56.5 0 56.3 4.9 4- 
pyrimidyl 
4:s-~imethyl- 198 PY 71 
pyrimidyl 
2,6-Dimethoxy 194 Y 70 
pyrimidyl 
94 S C Nigam et al. 
S. aureus. The interchange from halogen to the nitro group further enhances the 
activity against S. aureus. 
In 1-methyl-3-aryl-2-(N-substituted p-sulphamy1benzeneazo)propane-1,3-diones 
the replacement of the phenyl ring attached at Nf-position of the sulphonamide residue 
by a six membered heterocyclic ring caused an increase in activity particularly against 
S. aureus and & coli, while a five membered hetrocyclic ring decreases the activity. 
The order of activity against the three micro-organism is P. pyocyanea > S. aureus 
> E. coli in 2-arylazo derivatives and is S. aureus > E. coli > P. pyocyanea in case 
of 2-(N-substituted p-sulphamylbenzeneazo derivatives. 
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